Eupatilin

DB16885InvestigationalSmall molecule

Eupatilin: Overview.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha
Curator reviewed
Formula / weight: C₁₈H₁₆O₇ · 344.319 g/mol (avg)
Code names: NSC-122413

Resolves to

Compound

Structure

InChIKeyDRRWBCNQOKKKOL-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1OC)C1=CC(=O)C2=C(O)C(OC)=C(O)C=C2O1

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Eupatilin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.